Insights on Discovery
-
Case Study: Full Clonality Assessment Of CHO Cell Line
2/27/2026
In this case study, a comprehensive genetic analysis was performed on a transgenic Chinese hamster ovary (CHO) master cell bank to characterize the bank and provide high-confidence evidence of clonality.
-
Automated NGS Solutions Advance Rare Disease Research
2/27/2026
See how a unified NGS workflow is helping a major pediatric genetics lab boost efficiency, manage growing sample volumes, and accelerate insights into rare diseases through streamlined automation.
-
Develop A Comprehensive Strategy For Implementing AI & Multi-Omics
2/19/2026
Discover how a strategy-first approach to AI and multi-omics transforms complex biological data into actionable clinical decisions and more precise, targeted oncology therapies for 2026 and beyond.
-
From Promise To Patients: Smarter Pathways To Scale In Cell And Gene Therapy Manufacturing
2/12/2026
As the field evolves, the strategies developers choose may prove just as influential as the therapies themselves in determining how quickly innovation reaches patients.
-
Advancing An Integrated Biopharma Workflow Strategy
1/30/2026
Global research teams were generating critical data in disconnected systems, hindering collaboration. Explore how unified workflows and a shared data backbone strengthen efficiency.
-
Enhancing Biopharma ROI With In-House Long-Read Sequencing
1/29/2026
Long-read sequencing is redefining research by enabling clearer insights into complex genetic regions. Learn how this technology strengthens data confidence and accelerates modern R&D workflows.
-
Enhancing Novel Developability Through Automated MS Analytics
1/29/2026
Growing biotherapeutic complexity demands MS workflows that can unify diverse datasets. Learn how automated approaches enhance data quality, streamline analysis, and support faster development.
-
Transforming Development Through Mass Spectrometry Data Analysis
1/29/2026
Mass spectrometry is vital for understanding PTMs in modern biologics. Explore key challenges and how streamlined analysis can reveal deeper, more sensitive insights into biotherapeutic structure.
-
End-To-End Workflow Integration For Antibody Development
1/29/2026
Modern antibody discovery generates massive, fragmented datasets that slow collaboration and decision‑making. Examine how unified digital workflows streamline R&D and improve data quality.
-
Overcoming Analytical Bottlenecks In Oligonucleotide Drug Development With Automation
1/29/2026
Growing oligonucleotide complexity is straining traditional analytical workflows. See how automated LC‑UV‑MS processing offers a scalable way to boost throughput and reduce manual effort.